Consensus Enlivex Börse Stuttgart

Stocks

1BT

IL0011319527

Market Closed - Börse Stuttgart Other stock markets 09:31:40 2026-07-16 EDT			5-day change	1st Jan Change
5.050 ^EUR	+5.21%		-23.81%	-47.54%

06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT
06-01	Enlivex Ltd. Presents Durable 6-Month Efficacy Data For Allocetra In Knee Osteoarthritis Phase IIa Trial	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

5e5cd3f41b2d8730a867.c0utlkhiBl8dYiG-7XvM5Gn__FqmhEJjr2LilZ3-Y-w.ITqb8SMNYBZ1I0333Df4kDCYmSDlwA4Zylqh4-6XOo8iI5z4GTdyFC0seA~e643e46c0f8972e1370b17af91e99a81

Analysts' recommendations: Enlivex

24-06-11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
24-04-12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
23-09-25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
22-05-02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

4.750USD

Average target price

300.00USD

Spread / Average Target

+6,215.79%

High Price Target

300.00USD

Spread / Highest target

+6,215.79%

Low Price Target

300.00USD

Spread / Lowest Target

+6,215.79%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

4.750USD

Average target price

300.00USD

Spread / Average Target

+6,215.79%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener